NL
CVS icon

Navalign LLC’s CVS Health CVS Stock Holding History

Navalign LLC’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-92
Closed -$7.3K – 203
2025
Q4 		$7.3K Buy
+92
New +$7.25K ﹤0.01% 356
2025
Q1 		– Sell
-12,219
Closed -$549K – 115
2024
Q4 		$549K Sell
12,219
-384
-3% -$21.5K 0.16% 82
2024
Q3 		$792K Sell
12,603
-1,065
-8% -$62.1K 0.23% 71
2024
Q2 		$807K Buy
13,668
+1,284
+10% +$80.3K 0.25% 71
2024
Q1 		$988K Buy
12,384
+1,031
+9% +$78.8K 0.33% 58
2023
Q4 		$896K Buy
11,353
+232
+2% +$16.5K 0.31% 64
2023
Q3 		$776K Buy
11,121
+417
+4% +$29.5K 0.29% 70
2023
Q2 		$740K Buy
10,704
+508
+5% +$36.1K 0.3% 63
2023
Q1 		$758K Buy
10,196
+706
+7% +$59.2K 0.32% 60
2022
Q4 		$884K Sell
9,490
-365
-4% -$35.2K 0.36% 55
2022
Q3 		$940K Buy
9,855
+286
+3% +$28.3K 0.42% 42
2022
Q2 		$887K Sell
9,569
-109
-1% -$10.6K 0.39% 51
2022
Q1 		$976K Sell
9,678
-19
-0.2% -$2K 0.41% 49
2021
Q4 		$1M Sell
9,697
-375
-4% -$34.7K 0.4% 50
2021
Q3 		$855K Buy
10,072
+179
+2% +$15K 0.36% 63
2021
Q2 		$825K Buy
9,893
+557
+6% +$45.6K 0.35% 65
2021
Q1 		$702K Buy
+9,336
New +$680K 0.31% 70

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Navalign LLC's CVS Position: Q1 2026 in Review

Navalign LLC sold out of CVS Health (CVS) in Q1 2026, closing a stake of 92 shares — an estimated $7.3K sold.

Navalign LLC first reported a position in CVS in Q1 2021 and held it in 17 quarters. The position peaked at $1M in Q4 2021. 1,873 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Navalign LLC reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • Navalign LLC sold 92 CVS Health shares in Q1 2026, an estimated $7.3K.
  • Navalign LLC first reported a position in CVS Health in Q1 2021 and held it in 17 quarters.
  • Navalign LLC's CVS Health position peaked at $1M in Q4 2021.
  • 1,873 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Navalign LLC's 13F filing for Q1 2026, filed 29 Apr 2026.